Results 181 to 190 of about 4,435,862 (297)

Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou, Christoforos K. Travlos, Lucas Lage Marinho, Thomas A. Mavrakanas, João Pedro Ferreira, Abhinav Sharma   +5 more
wiley   +1 more source

Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan. [PDF]

Drug Healthc Patient Saf
Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A.   +4 more
europepmc   +1 more source

Initiation of SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims‐Based Active‐Comparator New‐User Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To examine the association between initiation of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors and risk of incident depression compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors among adults with newly diagnosed Type 2 diabetes receiving metformin.
Sangwoo Park, Seogsong Jeong, Hye Jun Kim, Dae Ho Lee, Soo Jung Choi, Sang Min Park   +5 more
wiley   +1 more source

Pharmacogenomics of direct oral anticoagulants: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Chai H, Huo J, Chen H.
europepmc   +1 more source

A Biweekly GLP‐1R Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To develop a next‐generation, longer‐acting, more‐clinical‐benefits agonist to achieve sustained efficacy with improved tolerability. Methods CT130 was designed from semaglutide. Binding affinity was validated via molecular dynamics and cellular assays.
Wei Ding, Qing Liu, Qiong Luo, Xiaojun Yao, Xingxing Fan   +4 more
wiley   +1 more source

Resumption of Direct Oral Anticoagulants After Gastrointestinal Bleeding in Atrial Fibrillation: A Systematic Review of Timing and Clinical Outcomes. [PDF]

Cureus
Jad Allah B, Haider A, Shaikh SS, Botsa K, Quadir A, Devi R.   +5 more
europepmc   +1 more source

In Vitro Evaluation of the Efficacy of Liquid Platelet‐Rich Fibrin (PRF) for Maintaining and Restoring Periodontal Ligament Cell Viability in Avulsed Teeth After 3 and 4 h of Extra‐Alveolar Dry Time

Dental Traumatology, EarlyView.
ABSTRACT Background/Aim This in vitro study evaluated whether liquid platelet‐rich fibrin could maintain or recover periodontal ligament cell viability in extracted human teeth after three and four hours of dry extra‐alveolar time. Material and Methods Sixty‐six erupted third molars with complete root formation were allocated to four groups: three‐hour
Tatiana Carvalho Kowaltschuk, Mariana Martins Juglair, Daniel Grigolo, Fabiane Barchiki, Lorena Bortolini Navarro, Everdan Carneiro, Vânia Portela Ditzel Westphalen   +6 more
wiley   +1 more source

Re: Systematic Scoping on Point-of-care Monitoring of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation. [PDF]

Eur Cardiol
Danjuma MI, Bassut R, Bakir L, Elshafei MN.   +3 more
europepmc   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

European Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro, Antonio Chistolini   +12 more
wiley   +1 more source

Correction: Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants. [PDF]

Thromb J
Altamura N, Di Girolamo FG, Pradella P, Cavalet M, Pellicori F, Vinci P, Panizon E, Cominotto G, Zaccari M, Galasso I, La Rocca P, Teraž K, La Raja M, Fiotti N, Biolo G.   +14 more
europepmc   +1 more source